Pharmachem Laboratories, Inc.: 2016 Company Profiles
265 Harrison Ave.
Kearny, NJ 07032
Phone: (800) 526-0609 • Fax: (201) 246-8105
Pharmachem: Making Ingredients Work
David Holmes founded Pharmachem in 1979 following the purchase of Stanley Blackman Laboratories, Kearny, NJ, where he was employed.
From its humble beginnings with just one production facility and nine employees, Pharmachem Laboratories grew into a major supplier of custom and specialty nutritional ingredients, as well as process services. Today, Pharmachem has grown to more than 16 manufacturing facilities in the U.S. and Mexico.
Throughout the 1980s, Pharmachem invested heavily in new technology and equipment to improve its granulation techniques, to make its ingredients easier to form into tablets.
After the passing of the Dietary Supplement Health Education Act, (DSHEA) in 1994, which freed the industry from cumbersome pharmaceutical-style regulation, Holmes quickly recognized the potential of the young industry, and made several strategic acquisitions.
In 2003, the company purchased AVOCA, Inc., Merry Hill, NC, the largest botanical extraction facility in the Eastern U.S.; followed by American Ingredients with West Coast distribution, warehousing and customer service base; Avoca BioProcessing, Menomonee Falls, WI, a dairy ingredient and natural product processing facility; Alera Technologies, Utah, specializing in liquid nutritional formulas, household products, cosmetics and personal care; Improve USA, a fully integrated aloe vera manufacturing company, with facilities and farms in Mexico; and Powder Processors, Inc., Ogden, UT, a manufacturer of a wide range of nutritional ingredient powders, including tablet and capsule-ready blends.
As a result of the acquisitions, Pharmachem was positioned as a vertically integrated company literally capable of adding value to ingredients at every step in the production process—from extraction to encapsulation. This capability is neatly captured in the company’s slogan: “We Make Ingredients Work.”
Pharmachem’s proprietary branded ingredient portfolio includes:
• Phase 2 Carb Controller (Weight and glucose control)
• Lactium (Mood/anxiety/stress/sleep support)
• Cran-Max (Women’s health/UTI support)
• Probiotical (Probiotics)
• Benexia (Plant-based EFAs; wholesome nutrition)
• Celadrin (Joint support)
Pharmachem has developing a leading quality control staff enabling it to achieve several important industry certifications, including: NOP-Certified Organic; NSF cGMP; HACCP; AID Superior; Kosher and Halal.
Pharmachem is also a global leader in application-specific processing of healthy ingredients including:
• Custom extraction
• Liquid-to-powder conversion
• Nutrient fortification
• Ready-to-drink powders
• Beverage processing and packaging
Pharmachem Laboratories was founded on the belief that quality human clinical studies provide consumers—and the retailers who serve them—with the ultimate in trust that the supplement will be safe and effective in achieving their health goals. Here are some key highlights:
Fourteen separate clinical studies have been completed with Phase 2 Carb Controller in the last 15 years. In the most recent and largest human study conducted on Phase 2 Carb Controller to date, those subjects taking a proprietary extract of the white bean, PhaseLite (Phase 2 Carb Controller) lost an average of seven pounds more than those on placebo after 12 weeks. In addition, 73.5 percent of the participants in the weight management phase successfully maintained their body weight after 24 weeks. Study results were published in the journal, Obesity.
Lactium also has several clinical studies. In a new study published in the Journal of International Medical Research, a consumer product called Target 1—in a formula featuring Lactium (milk casein)—helped significantly decrease symptoms of burnout. In the placebo group, 14 participants still presented with a high level of burnout at the end of the trial compared with 26 on the first day, whereas in the supplement group, only two participants had a high level of burnout at the end of the trial compared with 33 on the first day.
A groundbreaking clinical study with Cran-Max, published in the Journal of Antimicrobial Chemotherapy, has shown that the administration of Cran-Max was comparable to the commonly prescribed antibiotic, trimethoprim, for the prevention of recurrent urinary tract infections in older women.
For joint health, Celadrin has been shown in several studies to help increase knee range of motion while also lessening discomfort. This has been achieved in both supplement and topical form, making Celadrin a versatile product.